Other neonatal hypocalcemia
ICD-10 P71.1 is a billable code used to indicate a diagnosis of other neonatal hypocalcemia.
Other neonatal hypocalcemia (P71.1) refers to a condition characterized by low serum calcium levels in newborns, which can lead to various clinical manifestations. This condition is often transitory and can arise from several factors, including maternal vitamin D deficiency, prematurity, or parathyroid hormone dysfunction. Hypocalcemia in neonates may present with symptoms such as jitteriness, muscle twitching, seizures, or poor feeding. The diagnosis is typically confirmed through serum calcium measurements, and treatment may involve calcium supplementation or addressing underlying causes. It is crucial for healthcare providers to monitor calcium levels in at-risk infants, particularly those born prematurely or with low birth weight, as they are more susceptible to metabolic disturbances. Understanding the etiology and management of neonatal hypocalcemia is essential for optimizing outcomes in this vulnerable population.
Detailed records of calcium levels, clinical symptoms, and treatment plans are essential.
Neonates presenting with jitteriness or seizures in the NICU, requiring calcium level assessment.
Consideration of maternal health history and potential genetic factors influencing calcium metabolism.
Documentation should include growth parameters and developmental assessments.
Pediatric follow-up for infants with a history of neonatal hypocalcemia.
Monitoring for long-term effects of hypocalcemia on growth and development.
Used to confirm diagnosis of hypocalcemia in neonates.
Document the indication for the test and results.
Neonatologists should ensure timely testing in at-risk infants.
Common causes include maternal vitamin D deficiency, prematurity, and parathyroid hormone dysfunction. It is important to assess the infant's clinical history and laboratory results to determine the underlying cause.
